Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
27.76%
↑ 104% above average
Average (26q)
-785.09%
Historical baseline
Range
High:1545.68%
Low:-22237.14%
Volatility
-3029.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 27.76% |
| Q2 2025 | -44.44% |
| Q1 2025 | -1.79% |
| Q4 2024 | -17.47% |
| Q3 2024 | 3.49% |
| Q2 2024 | -13.14% |
| Q1 2024 | -56.06% |
| Q4 2023 | 39.25% |
| Q3 2023 | -21.63% |
| Q2 2023 | 44.42% |
| Q1 2023 | -116.42% |
| Q4 2022 | -7.97% |
| Q3 2022 | -114.18% |
| Q2 2022 | 1545.68% |
| Q1 2022 | 62.79% |
| Q4 2021 | -87.40% |
| Q3 2021 | -10.96% |
| Q2 2021 | -22237.14% |
| Q1 2021 | 99.75% |
| Q4 2020 | -187.54% |
| Q3 2020 | -14.34% |
| Q2 2020 | -73.38% |
| Q1 2020 | -8.84% |
| Q4 2019 | 30.59% |
| Q3 2019 | -38.53% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |